Navigation Links
Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
Date:4/23/2012

FARMINGTON, Conn., April 23, 2012 /PRNewswire-iReach/ -- Global Information Inc. is announces limited time remaining to purchase Early Bird discounted registration for three important Boston healthcare conferences:

Next-Gen Kinase Inhibitors 2012

Pioneers from across the rapidly maturing kinase inhibitors field will gather to explore the exciting question of what lies ahead at the Next-Gen Kinase Inhibitors Conference in Cambridge, MA. What is in store for the pharmaceutical industry and what new avenues are opening up for new technologies and methods as novel targets and therapeutic approaches are explored? What ground-breaking kinase indications are being discovered, and what other therapeutic areas are blossoming? Topics include key issues around addressing resistance; selectivity versus safety; developing lead compounds; the integration of chemistry and biology, and much more.

Save up to $200 by registering before April 27! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/chi214653-2012/

Structure-Based Drug Design Conference 2012

Structure-based drug design took nearly two decades of multiple, parallel technological improvements to arrive at its current mainstream position in medicinal chemistry. At the 12th Annual Structure-Based Drug Design Conference in Cambridge, MA an accomplished faculty of experts will bring to focus recent advancements in this evolving and dynamic field. Attendees will learn about developments in computer graphics, high-power radiation sources, computational processing power, refinement protocols, virtual screening and crystallography, all technolgies that are absolutely necessary to create the environment for rapid, iterative structure-based drug discovery.

Save up to $200 by registering before April 27! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/woco224416-2012/

mHealth World Congress 2012

Mobile health (mHealth) is a revolution, changing everything in the healthcare industry from the way consumers engage in healthy behaviors to the way patients manage their care; from how physicians manage their practices to payers interact with their members. Thousands of apps for smartphones and sophisticated health monitoring tools have been developed to not only improve efficiency for care management, but also open up new lines of communication between physicians and their patients and colleagues.

The 4th Annual mHealth World Congress 2012 in Boston, July 25-27, gathers international health care and technology executives to discuss the latest applications and strategic initiatives for mobile technologies as they transform the future of health care. Over two days attendees will have the opportunity to engage in keynote presentations, debates, summits, case studies, and innovation trend forums to hear from healthcare providers, health plans, developers, employers manufacturers, and distributors on the opportunities and the sustainable business models being rapidly deployed that are changing access and delivery of care.

Save up to $800 by registering before May 18! Additional information and Early Bird discounted rates are available at http://www.giiconference.com/woco224424-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Chemist to donate potential pharmaceutical royalties to Madagascar
2. Donation for new Center for Pharmaceutical Nanotechnology and Nanotoxicology
3. Anadys Pharmaceuticals to Present at the Roth OC Growth Stock Conference
4. Simulating pharmaceutical and personal care product transport
5. Researchers prolong the half-life of biopharmaceutical proteins
6. InVivo and CEVEC pharmaceuticals sign license agreement regarding the use of human CAP-T Technology for production of recombinant proteins
7. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
8. TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services
9. NIH awards $8.5 million for research on pharmaceuticals for children
10. Biostar Pharmaceuticals, Inc. Receives New Advertising Approval from Shaanxi SFDA for Marketing Xin Aoxing Capsule
11. ACS Green Chemistry Institute Pharmaceutical Roundtable award goes to Scottish chemist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... 7, 2016   Avanade is helping Williams ... teams in history, exploit biometric data in order to ... maintain the competitive edge against their rivals after their ... Avanade has worked with Williams during the 2016 ... data (heart rate, breathing rate, temperature and peak acceleration) ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE ... priced an offering of €500.0 million principal amount of its ... amount of its 2.425% senior unsecured notes due 2026. ... occur on December 13, 2016, subject to the satisfaction of customary ... basis. The Company intends to ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, a ... heart failure and type 2 diabetes, announced that ... novel adeno-associated virus (AAV) vector developed in the ... Ph.D., at Stanford University. The company plans to ... gene therapy product pipeline. "Early ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a standard ...
(Date:12/8/2016)... 2016  Anaconda BioMed S.L., a pre-clinical stage medical ... generation neuro-thrombectomy system for the treatment of Acute Ischemic ... MD to join its Scientific Advisory Board (SAB). The ... of scientific and clinical experts to Anaconda BioMed S.L., ... BRAIN ® to its clinical phase. The SAB ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, ... uBiome is one of just six company finalists in the Health & Medicine ... uBiome, companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, ...
Breaking Biology Technology: